stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / BIO / Free Cash Flow

Bio-Rad Laboratories, Inc. Free Cash Flow 2008–2025

Bio-Rad Laboratories, Inc. (BIO) annual free cash flow by fiscal year, computed from SEC filings. Compound growth +7.7%/yr over 17 years.

Fiscal yearFree Cash FlowChange (YoY)
FY 2025$374.60M+29.4%
FY 2024$289.60M+32.7%
FY 2023$218.20M+167.4%
FY 2022$81.60M-84.8%
FY 2021$535.72M+12.4%
FY 2020$476.41M+32.6%
FY 2019$359.37M+130.9%
FY 2018$155.67M+2263.6%
FY 2017$-7.20M-109.6%
FY 2016$74.63M+0.6%
FY 2015$74.21M-51.3%
FY 2014$152.31M+143.8%
FY 2013$62.48M-49.5%
FY 2012$123.61M-22.7%
FY 2011$159.85M+16.3%
FY 2010$137.46M-46.5%
FY 2009$257.03M+141.2%
FY 2008$106.56M

Source: Bio-Rad Laboratories, Inc. SEC filings — cash flow statement (10-K). Refreshed nightly.

See the full picture for Bio-Rad Laboratories, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Bio-Rad Laboratories, Inc. — frequently asked questions

What is Bio-Rad Laboratories, Inc.'s free cash flow?

Bio-Rad Laboratories, Inc. (BIO) reported free cash flow of $374.60M for fiscal year 2025, per its SEC filings.

How has Bio-Rad Laboratories, Inc.'s free cash flow changed over time?

Between fiscal 2008 and 2025, BIO's free cash flow grew at roughly 7.7% per year (compound annual rate), from $106.56M to $374.60M.

Where does this data come from?

Figures are computed from Bio-Rad Laboratories, Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.

More BIO financial history

Full BIO fundamentals page → · All 1,500+ companies →